InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,018.39
(
0.00%
)
US TECH 100
17,025.60
(
0.98%
)
Dow Jones
37,903.29
(
0.00%
)
Brent Oil
83.53
(
-0.02%
)
Bitcoin
58,644.86
(
0.70%
)
Post# of 7587
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

learningcurve2020

Send PM Follow Ignore
Followers 44
Posts 14702
Boards Moderated 0
Alias Born 09/16/2012

learningcurve2020

Re: DNORWOOD post# 7552

Monday, 03/25/2024 9:30:50 AM

Monday, March 25, 2024 9:30:50 AM

Post# of 7587
12 to 2 tells me they've got side effects under control. Can you imagine if Imetelstat can target telomerase in most all cancers to simply inhibit the proliferation of malignant stem and progenitor cells, while in combo with other therapies! It'd be a game changer.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent GERN News
More GERN News
InvestorsHub NewsWire

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!